Biological,Clinical,and Sociobehavioral Factors Associated with Disproportionate Burden of Bacterial Vaginosis in the United States: A Comprehensive Literature Review
Restricted accessResearch articleFirst published online May, 2025
Biological,Clinical,and Sociobehavioral Factors Associated with Disproportionate Burden of Bacterial Vaginosis in the United States: A Comprehensive Literature Review
Bacterial vaginosis (BV), a common gynecological infection characterized by reduced lactic acid-producing bacteria and increased anerobic bacteria in the vaginal microbiome, is associated with adverse health outcomes.
Methods:
A PubMed search for English-language articles about BV in the USA and factors contributing to disparities in BV risk, with an emphasis on the role of the vaginal microbiome, published from August 2012 to August 2022, identified 760 articles.
Results:
Among the 52 articles meeting the prespecified criteria, BV prevalence varied among different populations and disproportionately impacted Black women (49–51%), Hispanic ethnicity (32–43%), and women of reproductive age (30%). Differences in microbial ecology and host genetics were important factors underlying these disparities. Colonization of BV-associated bacteria was more common in women of color than in non-Hispanic White women. Other factors linked with disproportionate burden included multiple/same-sex partners, obesity, immunosuppression, and C-section birth.
Conclusions:
BV prevalence was multifactorial, with some populations having higher prevalence rates and distinctive microbiome profiles that may predispose them to the condition. BV treatment and recurrence prevention were challenging due to the complex interplay of biological, clinical, and sociobehavioral factors. Understanding these disparate risk factors is critical to reducing BV burden.
Get full access to this article
View all access options for this article.
References
1.
KoumansEH, SternbergM, BruceC, et al.The prevalence of bacterial vaginosis in the United States, 2001–2004; associations with symptoms, sexual behaviors, and reproductive health. Sex Transm Dis, 2007; 34(11):864–869; doi: 10.1097/OLQ.0b013e318074e565
2.
MuznyCA, BalkusJ, MitchellC, et al.Diagnosis and management of bacterial vaginosis: Summary of evidence reviewed for the 2021 centers for disease control and prevention sexually transmitted infections treatment guidelines. Clin Infect Dis, 2022; 74(Suppl_2):S144–S151; doi: 10.1093/cid/ciac021
3.
WatkinsE, ChowCM, Lingohr-SmithM, et al.Treatment patterns and economic burden of bacterial vaginosis among commercially insured women in the USA. J Comp Eff Res, 2024; 13(1):e230079; doi: 10.57264/cer-2023-0079
4.
PeeblesK, VellozaJ, BalkusJE, et al.High global burden and costs of bacterial vaginosis: A systematic review and meta-analysis. Sex Transm Dis, 2019; 46(5):304–311; doi: 10.1097/OLQ.0000000000000972
5.
VodstrcilLA, MuznyCA, PlummerEL, et al.Bacterial vaginosis: Drivers of recurrence and challenges and opportunities in partner treatment. BMC Med, 2021; 19(1):194–112; doi: 10.1186/s12916-021-02077-3
6.
HickeyRJ, ZhouX, PiersonJD, et al.Understanding vaginal microbiome complexity from an ecological perspective. Transl Res, 2012; 160(4):267–282; doi: 10.1016/J.TRSL.2012.02.008
7.
GreenKA, ZarekSM, CatherinoWH. Gynecologic health and disease in relation to the microbiome of the female reproductive tract. Fertil Steril, 2015; 104(6):1351–1357; doi: 10.1016/J.FERTNSTERT.2015.10.010
8.
OlsonKM, BoohakerLJ, SchwebkeJR, et al.Comparisons of vaginal flora patterns among sexual behaviour groups of women: Implications for the pathogenesis of bacterial vaginosis. Sex Health, 2018; 15(1):61–67; doi: 10.1071/SH17087
9.
TamarelleJ, ShardellMD, RavelJ, et al.Factors associated with incidence and spontaneous clearance of molecular-bacterial vaginosis: Results from a longitudinal frequent-sampling observational study. Sex Transm Dis, 2022; 49(9):649–656; doi: 10.1097/OLQ.0000000000001662
10.
NserekoE, MorelandPJ, DunlopAL, et al.Consideration of cultural practices when characterizing the vaginal microbiota among African and African American women. Biol Res Nurs, 2021; 23(1):91–99; doi: 10.1177/1099800420940788
11.
CoudrayMS, SheehanDM, LiT, et al.Factors associated with the recurrence, persistence, and clearance of asymptomatic bacterial vaginosis among young African American women: A repeated-measures latent class analysis. Sex Transm Dis, 2020; 47(12):832–839; doi: 10.1097/OLQ.0000000000001256
12.
PentikisH, AdetoroN, TippingD, et al.An integrated efficacy and safety analysis of single-dose secnidazole 2 g in the treatment of bacterial vaginosis. Reprod Sci, 2020; 27(2):523–528; doi: 10.1007/s43032-019-00048-x
13.
Abou ChacraL, FenollarF, DiopK. Bacterial vaginosis: What do we currently know? Front Cell Infect Microbiol, 2021; 11:672429.
14.
MurphyK, MitchellCM. The interplay of host immunity, environment and the risk of bacterial vaginosis and associated reproductive health outcomes. J Infect Dis, 2016; 214(Suppl 1):S29–S35; doi: 10.1093/infdis/jiw140
15.
Swaims-KohlmeierA, HaddadLB, LiTZR, et al.Chronic immune barrier dysregulation among women with a history of violence victimization. JCI Insight, 2019; 4(10):7–10; doi: 10.1172/jci.insight.126097
16.
YangL, HaoY, HuJ, et al.Differential effects of depot medroxyprogesterone acetate administration on vaginal microbiome in Hispanic White and Black women. Emerg Microbes Infect, 2019; 8(1):197–210; doi: 10.1080/22221751.2018.1563458
17.
FettweisJM, BrooksP, SerranoJ, et al.Differences in vaginal microbiome in African American women versus women of European ancestry. Microbiology (Reading), 2014; 160(Pt 10):2272–2282; doi: 10.1099/mic.0.081034-0
18.
GuptaA, CoxC, DunivanGC, et al.Desire for continued pessary use among women of Hispanic and non-Hispanic ethnic backgrounds for pelvic floor disorders. Female Pelvic Med Reconstr Surg, 2019; 25(2):172–177; doi: 10.1097/SPV.0000000000000652
19.
SalazarAS, NogueiraNF, RodriguezVJ, et al.A syndemic approach to explore factors associated with bacterial vaginosis. AIDS Behav, 2022; 26(9):3110–3118; doi: 10.1007/s10461-022-03634-4
20.
NelsonDB, KomaroffE, NachamkinI, et al.Relationship of selected bacterial vaginosis (BV)-Associated bacteria to Nugent-score BV among urban women early in pregnancy. Sex Transm Dis, 2013; 40(9):721–723; doi: 10.1097/OLQ.0000000000000001
21.
MitchellC, GottschML, LiuC, et al.Associations between vaginal bacteria and levels of vaginal defensins in pregnant women. Am J Obstet Gynecol, 2013; 208(2):132.e1–132.e7; doi: 10.1016/j.ajog.2012.11.019
22.
AlcendorDJ. Evaluation of health disparity in bacterial vaginosis and the implications for HIV-1 Acquisition in African American Women. Am J Reprod Immunol, 2016; 76(2):99–107; doi: 10.1111/aji.12497
23.
WellsJS, ChandlerR, DunnA, et al.The vaginal microbiome in U.S. Black women: A systematic review. J Womens Health (Larchmt), 2020; 29(3):362–375; doi: 10.1089/jwh.2019.7717
24.
BeamerMA, AustinMN, AvoliaHA, et al.Bacterial species colonizing the vagina of healthy women are not associated with race. Anaerobe, 2017; 45:40–43; doi: 10.1016/j.anaerobe.2017.02.020
25.
TortelliBA, LewisWG, AllsworthJE, et al.Associations between the vaginal microbiome and Candida colonization in women of reproductive age. Am J Obstet Gynecol, 2020; 222(5):471.e1–471.e9; doi: 10.1016/j.ajog.2019.10.008
26.
WrightML, FettweisJM, EavesLJ, et al.Vaginal microbiome Lactobacillus crispatus is heritable among European American women. Commun Biol, 2021; 4(1):872–876; doi: 10.1038/s42003-021-02394-6
27.
BorgognaJLC, AnastarioM, FiremoonP, et al.Vaginal microbiota of American Indian women and associations with measures of psychosocial stress. PLoS One, 2021; 16(12):e0260813; doi: 10.1371/journal.pone.0260813
28.
StennettCA, DyerTV, HeX, et al.A cross-sectional pilot study of birth mode and vaginal microbiota in reproductive-age women. PLoS One, 2020; 15(4):e0228574; doi: 10.1371/journal.pone.0228574
29.
HoffmannJN, YouHM, HedbergEC, et al.Prevalence of bacterial vaginosis and Candida among postmenopausal women in the United States. J Gerontol B Psychol Sci Soc Sci, 2014; 69(Suppl 2):S205–S214; doi: 10.1093/geronb/gbu105
30.
WatsonLTJ, JamesKE, Hatoum MoellerIJ, et al.Vulvovaginal discomfort is common in both premenopausal and postmenopausal women. J Low Genit Tract Dis, 2019; 23(2):164–169; doi: 10.1097/LGT.0000000000000460
31.
NoyesN, ChoKC, RavelJ, et al.Associations between sexual habits, menstrual hygiene practices, demographics and the vaginal microbiome as revealed by Bayesian network analysis. PLoS One, 2018; 13(1):e0191625; doi: 10.1371/journal.pone.0191625
32.
MuznyCA, SunesaraIR, KumarR, et al.Characterization of the vaginal microbiota among sexual risk behavior groups of women with bacterial vaginosis. PLoS One, 2013; 8(11):e80254; doi: 10.1371/journal.pone.0080254
33.
TakemotoMLS, De Oliveira MenezesM, PolidoCBA, et al.Prevalence of sexually transmitted infections and bacterial vaginosis among lesbian women: Systematic review and recommendations to improve care. Cad Saude Publica, 2019; 35(3):e00118118; doi: 10.1590/0102-311X00118118
34.
MuznyCA, LensingSY, AaronKJ, et al.Incubation period and risk factors support sexual transmission of bacterial vaginosis in women who have sex with women. Sex Transm Infect, 2019; 95(7):511–515; doi: 10.1136/SEXTRANS-2018-053824
35.
MuznyCA, AustinEL, HarbisonHS, et al.Sexual partnership characteristics of African American women who have sex with women; impact on sexually transmitted infection risk. Sex Transm Dis, 2014; 41(10):611–617; doi: 10.1097/OLQ.0000000000000194
36.
MuznyCA, HarbisonHS, AustinEL, et al.Sexually transmitted infection risk among women is not fully explained by partner numbers. South Med J, 2017; 110(3):161–167; doi: 10.14423/SMJ.0000000000000621
37.
MuznyCA, SunesaraIR, AustinEL, et al.Bacterial vaginosis among African American women who have sex with women. Sex Transm Dis, 2013; 40(9):751–755; doi: 10.1097/OLQ.0000000000000004
38.
MuznyCA, SchwebkeJR. Editorial commentary: Women who have sex with women: A unique population for studying the pathogenesis of bacterial vaginosis. Clin Infect Dis, 2015; 60(7):1054–1056; doi: 10.1093/cid/ciu1132
39.
AllenNG, EdupugantiL, EdwardsDJ, et al;Vaginal Microbiome Consortium. The vaginal microbiome in women of reproductive age with healthy weight versus overweight/obesity. Obesity (Silver Spring), 2022; 30(1):142–152; doi: 10.1002/oby.23306
40.
BrookheartRT, LewisWG, PeipertJF, et al.Association between obesity and bacterial vaginosis as assessed by Nugent score. Am J Obstet Gynecol, 2019; 220(5):476.e1–476.e11; doi: 10.1016/j.ajog.2019.01.229
41.
DaubertE, WeberKM, FrenchAL, et al.Obesity is associated with lower bacterial vaginosis prevalence in menopausal but not premenopausal women in a retrospective analysis of the Women’s Interagency HIV Study. PLoS One, 2021; 16(3):e0248136; doi: 10.1371/journal.pone.0248136
42.
BrotmanRM, HeX, GajerP, et al.Association between cigarette smoking and the vaginal microbiota: A pilot study. BMC Infect Dis, 2014; 14(1):471–411; doi: 10.1186/1471-2334-14-471
43.
NelsonTM, BorgognaJC, MichalekRD, et al.Cigarette smoking is associated with an altered vaginal tract metabolomic profile. Sci Rep, 2018; 8(1):852–813; doi: 10.1038/s41598-017-14943-3
44.
FroehleL, GhanemKG, PageK, et al.Bacterial vaginosis and alcohol consumption: A cross-sectional retrospective study in Baltimore, Maryland. Sex Transm Dis, 2021; 48(12):986–990; doi: 10.1097/OLQ.0000000000001495
45.
TurpinR, BrotmanRM, MillerRS, et al.Perceived stress and incident sexually transmitted infections in a prospective cohort. Ann Epidemiol, 2019; 32:20–27; doi: 10.1016/j.annepidem.2019.01.010
46.
TurpinR, SlopenN, BorgognaJLC, et al.Perceived stress and molecular bacterial vaginosis in the national institutes of health longitudinal study of vaginal flora. Am J Epidemiol, 2021; 190(11):2374–2383; doi: 10.1093/aje/kwab147
47.
ChehoudC, StiehDJ, BaileyAG, et al.Associations of the vaginal microbiota with HIV infection, bacterial vaginosis and demographic factors. AIDS, 2017; 31(7):895–904; doi: 10.1097/QAD.0000000000001421
48.
MassadLS, EvansCT, KangR, et al.Correlates of bacterial vaginosis over long-term follow-up: Impact of HIV infection. AIDS Res Hum Retroviruses, 2017; 33(5):432–439; doi: 10.1089/aid.2016.0213
49.
BaiJ, JhaneyI, DanielG, et al.Pilot study of vaginal microbiome using QIIME 2TM in Women with gynecologic cancer before and after radiation therapy. Oncol Nurs Forum, 2019; 46(2):E48–E59; doi: 10.1188/19.ONF.E48-E59
50.
TsementziD, Pena-GonzalezA, BaiJ, et al.Comparison of vaginal microbiota in gynecologic cancer patients pre- and postradiation therapy and healthy women. Cancer Med, 2020; 9(11):3714–3724; doi: 10.1002/cam4.3027
51.
BrownJM, HessKL, BrownS, et al.Intravaginal practices and risk of bacterial vaginosis and candidiasis infection among a cohort of women in the United States. Obstet Gynecol, 2013; 121(4):773–780; doi: 10.1097/AOG.0b013e31828786f8
52.
BrownJM, PoirotE, HessKL, et al.Motivations for intravaginal product use among a cohort of women in Los Angeles. PLoS One, 2016; 11(3):e0151378; doi: 10.1371/journal.pone.0151378
53.
Kostas-PolstonEA, BraunLA, MiedemaJ. Female warfighters’ perceptions of urogenital health in operational settings. J Am Assoc Nurse Pract, 2020; 32(11):729–737; doi: 10.1097/JXX.0000000000000534
54.
MassadLS, DaubertEM, EvansCT, et al.Trends in bacterial vaginosis prevalence in a cohort of U.S. Women with and at risk for HIV. J Womens Health (Larchmt), 2022; 31(5):726–732; doi: 10.1089/jwh.2021.0102
55.
BautistaCT, WurapaE, SaterenWB, et al.Bacterial vaginosis: A synthesis of the literature on etiology, prevalence, risk factors, and relationship with chlamydia and gonorrhea infections. Mil Med Res, 2016; 3(1):4–10; doi: 10.1186/s40779-016-0074-5
56.
CoudrayMS, MadhivananP. Bacterial vaginosis-A brief synopsis of the literature. Eur J Obstet Gynecol Reprod Biol, 2020; 245:143–148; doi: 10.1016/j.ejogrb.2019.12.035
57.
RavelJ, MorenoI, SimónC. Bacterial vaginosis and its association with infertility, endometritis, and pelvic inflammatory disease. Am J Obstet Gynecol, 2021; 224(3):251–257; doi: 10.1016/j.ajog.2020.10.019
58.
BilardiJE, WalkerS, Temple-SmithM, et al.The burden of bacterial vaginosis: Women’s experience of the physical, emotional, sexual and social impact of living with recurrent bacterial vaginosis. PLoS One, 2013; 8(9):e74378; doi: 10.1371/JOURNAL.PONE.0074378
59.
HillierSL, AustinM, MacioI, et al.Diagnosis and treatment of vaginal discharge syndromes in community practice settings. Clin Infect Dis, 2021; 72(9):1538–1543; doi: 10.1093/cid/ciaa260
60.
MarkKS, TenorioB, StennettCA, et al.Bacterial vaginosis diagnosis and treatment in postmenopausal women: A survey of clinician practices. Menopause, 2020; 27(6):679–683; doi: 10.1097/GME.0000000000001515
61.
AmselR, TottenPA, SpiegelCA, et al.Nonspecific vaginitis. Diagnostic criteria and microbial and epidemiologic associations. Am J Med., 1983; 74(1):14–22; doi: 10.1016/0002-9343(83)91112-9
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
